Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Oxitec launches field trial in Brazil for next generation addition to Friendly mosquitoes platform

Published 05/24/2018, 08:30 AM
© Reuters.  Oxitec launches field trial in Brazil for next generation addition to Friendly mosquitoes platform
PGEN
-
  • Oxitec Ltd, a wholly owned subsidiary of Intrexon Corporation (NYSE:XON), announces that the newest addition to its Friendly Aedes aegypti mosquito line, "OX5034", has initiated open field trials on May 23.
  • The trial is designed to generate data for an application to Brazil's regulatory agency, the National Technical Commission for Biosecurity, to secure approval for commercial use of the new Friendly Mosquitoes throughout the country.
  • OX5034 is the next generation of Oxitec's non-biting Friendly Aedes mosquitoes, designed to reduce populations of the disease-spreading Aedes aegypti mosquito. It offers significant advances from the first generation mosquito, known as "OX513A".
  • Now read: Omeros announces settlement of infringement suit against ANDA filer Lupin


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.